Journal article
Emerging clinical experience with vaccines against group B meningococcal disease
- Abstract:
-
The prevention of paediatric bacterial meningitis and septicaemia has recently entered a new era with the availability of two vaccines against capsular group B meningococcus (MenB). Both of these vaccines are based on sub-capsular proteins of the meningococcus, an approach that overcomes the challenges set by the poorly immunogenic MenB polysaccharide capsule but adds complexity to predicting and measuring the impact of their use.
This review describes the development and use of Men...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 219.3KB)
-
- Publisher copy:
- 10.1016/j.vaccine.2017.07.056
Authors
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Vaccine Journal website
- Volume:
- 36
- Issue:
- 36
- Pages:
- 5470-5476
- Publication date:
- 2017-08-01
- Acceptance date:
- 2017-07-17
- DOI:
- EISSN:
-
1873-2518
- ISSN:
-
0264-410X
Item Description
- Keywords:
- Pubs id:
-
pubs:708373
- UUID:
-
uuid:6bec8316-f7ba-49c4-86db-1cea462146fd
- Local pid:
- pubs:708373
- Source identifiers:
-
708373
- Deposit date:
- 2017-07-17
Terms of use
- Copyright holder:
- Elsevier Ltd
- Copyright date:
- 2017
- Notes:
- Copyright © 2017 Elsevier Ltd. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/j.vaccine.2017.07.056
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record